An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis

Abstract

AbstractThe blood–brain barrier (BBB) tightly regulates substance transport between the bloodstream and the brain. Models for the study of the physiological processes affecting the BBB, as well as predicting the permeability of therapeutic substances for neurological and neurovascular pathologies, are highly desirable. Existing models, such as Transwell utilizing‐models, do not mimic the extracellular environment of the BBB with their stiff, semipermeable, non‐biodegradable membranes. To help overcome this, we engineered electrospun membranes from poly L‐lactic acid in combination with a nanometric coating of poly(ethyl acrylate) (PEA) that drives fibrillogenesis of fibronectin, facilitating the synergistic presentation of both growth factors and integrin binding sites. Compared to commercial semi‐porous membranes, these membranes significantly improve the expression of BBB‐related proteins in brain endothelial cells. PEA‐coated membranes in combination with different growth factors and extracellular protein coatings reveal nerve growth factor (NGF) and fibroblast growth factor (FGF‐2) caused formation of better barriers in vitro. This BBB model offers a robust platform for studying key biochemical factors influencing barrier formation that marries the simplicity of the Transwell model with the highly tunable electrospun PEA‐fibronectin membranes. This enables the generation of high‐throughput drug permeability models without the need of complicated co‐culture conditions.